This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Berchtold, C.
Right arrow Articles by Rüssmann, H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berchtold, C.
Right arrow Articles by Rüssmann, H.

 Previous Article  |  Next Article 

Infection and Immunity, December 2009, p. 5501-5508, Vol. 77, No. 12
0019-9567/09/$08.00+0     doi:10.1128/IAI.00700-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Superior Protective Immunity against Murine Listeriosis by Combined Vaccination with CpG DNA and Recombinant Salmonella enterica Serovar Typhimurium{triangledown} ,{dagger}

Christina Berchtold,1 Klaus Panthel,1 Stefan Jellbauer,1 Brigitte Köhn,1 Elisabeth Roider,1 Miriam Partilla,1 Jürgen Heesemann,1 Stefan Endres,2 Carole Bourquin,2 and Holger Rüssmann1,3*

Max von Pettenkofer Institute for Hygiene and Medical Microbiology, Ludwig Maximilians-University Munich, 80336 Munich,1 Center of Integrated Protein Science CIPS-M at the Division of Clinical Pharmacology, Department of Internal Medicine, Ludwig Maximilians-University Munich, 80336 Munich,2 HELIOS Clinic Emil von Behring, Institute for Microbiology, Immunology, and Laboratory Medicine, 14165 Berlin, Germany3

Received 22 June 2009/ Returned for modification 25 July 2009/ Accepted 13 September 2009

Preexisting antivector immunity can severely compromise the ability of Salmonella enterica serovar Typhimurium live vaccines to induce protective CD8 T-cell frequencies after type III secretion system-mediated heterologous protein translocation in orally immunized mice. To circumvent this problem, we injected CpG DNA admixed to the immunodominant p60217-225 peptide from Listeria monocytogenes subcutaneously into BALB/c mice and coadministered a p60-translocating Salmonella strain by the orogastric route. The distribution of tetramer-positive p60217-225-specific effector and memory CD8 T cells was analyzed by costaining of lymphocytes with CD62L and CD127. In contrast to the single oral application of recombinant Salmonella or single immunization with CpG and p60, in the spleens from mice immunized with a combination of both vaccine types a significantly higher level of p60-specific CD8 T cells with a predominance of the effector memory T-cell subset was detected. In vivo protection studies revealed that this CD8 T-cell population conferred sterile protective immunity against a lethal infection with L. monocytogenes. However, p60-specific central memory CD8 T cells induced by single vaccination with CpG and p60 were not able confer effective protection against rapidly replicating intracellular Listeria. In conclusion, we provide compelling evidence that the combination of Salmonella type III-mediated antigen delivery and CpG immunization is an attractive novel vaccination strategy to modulate CD8 differentiation patterns toward distinct antigen-specific T-cell subsets with favorable protective capacities.


* Corresponding author. Mailing address: HELIOS Clinic Emil von Behring, Institute for Microbiology, Immunology and Laboratory Medicine, Walterhöferstrasse 11, 14165 Berlin, Germany. Phone: 49-30-81021518. Fax: 49-30-81021909. E-mail: holger.ruessmann{at}helios-kliniken.de

{triangledown} Published ahead of print on 21 September 2009.

{dagger} Supplemental material for this article may be found at http://iai.asm.org/.

Editor: A. Camilli


Infection and Immunity, December 2009, p. 5501-5508, Vol. 77, No. 12
0019-9567/09/$08.00+0     doi:10.1128/IAI.00700-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.